The methylenetetrahydrofolate reductase (MTHFR) C677T (rs1801133) polymorphism influences folate metabolism and vascular function and has been investigated as a potential genetic modifier of LCPD susceptibility, though individual study findings remain inconsistent. The gene discussed is MTHFR; the disease is Legg-Calve-Perthes disease.